Table 2. The relationship between, pre-treatment measurements of ovarian response predictors and outcome (retrieval of a mature oocyte) after PRP treatment.

AFC PRIOR TO PRP	<35 years old (N/Total (%))	35-37 years old (N/Total (%))	38-40 years old (N/Total (%))	All ages (N/Total (%))
0a	11/73 (15.1%)*	9/37 (24.3%)	14/65 (21.5%)*	34/175 (19.4%)*
1 and 2b	19/34 (55.9%)*	10/25 (40.0%)	21/38 (55.3%)*	50/97 (51.5%)*
AMH PRIOR TO PRP	<35 years old (N/Total (%))	35-37 years old (N/Total (%))	38-40 years old (N/Total (%))	All ages (N/Total (%))
<25th percentilec (0.01-0.02 ng/mL)	2/34 (5.9%)†	4/15 (26.7%)	11/37 (29.7%)	17/86 (19.8%)†
25th -100th percentiled (0.03-0.82 ng/mL)	28/73 (38.4%)†	15/47 (31.9%)	24/66 (36.4%)	67/186 (36.0%)†
FSH PRIOR TO PRP	<35 years old (N/Total (%))	35-37 years old (N/Total (%))	38-40 years old (N/Total (%))	All ages (N/Total (%))
>75thpercentilee (44.2-155 mIU/mL)	1/30 (3.3%)‡	2/12 (16.7%)	2/26 (7.7%)‡	5/68 (7.4%)‡
0th -75th percentilef (25-44.1 mIU/mL)	29/77 (37.7%)‡	17/50 (34.0%)	33/77 (42.9%)‡	79/204 (38.7%)‡
TOTAL	30/107 (28.0%)	19/62 (30.6%)	35/103 (34.0%)	84/272 (30.9%)

Table shows the number of women who had at least one mature oocyte retrieved per women treated in each age group. Data shown as grouped according to pre-treatment AFC, AMH OR FSH. All women who participated in the study were included (n=311), except those who conceived spontaneously (n=23) and those who did not have all parameters recorded (n=16). *: p<0.05 in the age group according to pre-treatment AFC (0 vs 1 or 2); ^†: p<0.05 in the age group according to pre-treatment AMH (<25^th percentile vs 25^th-100^th percentile); ^‡: p<0.05 in the age group according to pre-treatment FSH (>75^th percentile vs 0^th-75^th percentile).